Cargando…

Diagnosis of gluten-related enteropathy in a newborn: how and when?

AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Assandri, Roberto, Montanelli, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820841/
https://www.ncbi.nlm.nih.gov/pubmed/31749915
_version_ 1783464029069508608
author Assandri, Roberto
Montanelli, Alessandro
author_facet Assandri, Roberto
Montanelli, Alessandro
author_sort Assandri, Roberto
collection PubMed
description AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first year of life is uncommon, which is due to the suboptimal sensitivity of tissue transglutaminase IgA antibodies (tTG-IgA) at this age and other possible causes of malabsorption in infants. The development of Deamidate gliadin peptide-specific antibodies (in particular DGP-IgG) in young children was poorly considered in the CD diagnosis. METHODS: We conducted a retrospective cross-sectional study on children between one month and forty-eight months of life, which performed in our health center from 2016 to 2018. Three hundred and fifty children were selected according to strict inclusion criteria: positive for HLA-DQA1 and DQB1 alleles, positive anti tTG-IgA/IgG and/or positive DGP-IgG/IgA. Eighty-two children were selected and divided into two different groups of patients: Group one (forty newborns under twenty-four months of life) and Group two (children from twenty-five months to 48 months of life). RESULTS: Anti-DGP-IgG antibodies precede anti tTG-IgA seroconversion in children under two years in 80% of cases. Anti-DGP-IgG positive patients had milder symptomatic forms of CD than anti tTG-IgA positive children, characterized by gastrointestinal symptoms in the presence of normal growth, normal serum iron, and low MCH level. At tTG-IgA seroconversion, children present gastrointestinal clinical forms associated with impaired growth. The combined use of tTG-IgA and DGP-IgG antibodies upgrade the diagnostic sensitivity from 50% to 92%. CONCLUSION: Anti-DGP-IgG antibodies precede tTG-IgA seroconversion in newborns and identified two distinct clinical phenotypes. At this point, if you wanted to test your newborn patients for CD serology, how would you proceed?
format Online
Article
Text
id pubmed-6820841
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-68208412019-11-20 Diagnosis of gluten-related enteropathy in a newborn: how and when? Assandri, Roberto Montanelli, Alessandro Gastroenterol Hepatol Bed Bench Original Article AIM: To analyze the development of gliadin-specific immune responses in children with a genetic risk for CD and to determine whether these could be detected before the clinical onset of the disease by using immunological tests. BACKGROUND: Clinical manifestations of celiac disease (CD) in the first year of life is uncommon, which is due to the suboptimal sensitivity of tissue transglutaminase IgA antibodies (tTG-IgA) at this age and other possible causes of malabsorption in infants. The development of Deamidate gliadin peptide-specific antibodies (in particular DGP-IgG) in young children was poorly considered in the CD diagnosis. METHODS: We conducted a retrospective cross-sectional study on children between one month and forty-eight months of life, which performed in our health center from 2016 to 2018. Three hundred and fifty children were selected according to strict inclusion criteria: positive for HLA-DQA1 and DQB1 alleles, positive anti tTG-IgA/IgG and/or positive DGP-IgG/IgA. Eighty-two children were selected and divided into two different groups of patients: Group one (forty newborns under twenty-four months of life) and Group two (children from twenty-five months to 48 months of life). RESULTS: Anti-DGP-IgG antibodies precede anti tTG-IgA seroconversion in children under two years in 80% of cases. Anti-DGP-IgG positive patients had milder symptomatic forms of CD than anti tTG-IgA positive children, characterized by gastrointestinal symptoms in the presence of normal growth, normal serum iron, and low MCH level. At tTG-IgA seroconversion, children present gastrointestinal clinical forms associated with impaired growth. The combined use of tTG-IgA and DGP-IgG antibodies upgrade the diagnostic sensitivity from 50% to 92%. CONCLUSION: Anti-DGP-IgG antibodies precede tTG-IgA seroconversion in newborns and identified two distinct clinical phenotypes. At this point, if you wanted to test your newborn patients for CD serology, how would you proceed? Shaheed Beheshti University of Medical Sciences 2019 /pmc/articles/PMC6820841/ /pubmed/31749915 Text en ©2019 RIGLD, Research Institute for Gastroenterology and Liver Diseases This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Assandri, Roberto
Montanelli, Alessandro
Diagnosis of gluten-related enteropathy in a newborn: how and when?
title Diagnosis of gluten-related enteropathy in a newborn: how and when?
title_full Diagnosis of gluten-related enteropathy in a newborn: how and when?
title_fullStr Diagnosis of gluten-related enteropathy in a newborn: how and when?
title_full_unstemmed Diagnosis of gluten-related enteropathy in a newborn: how and when?
title_short Diagnosis of gluten-related enteropathy in a newborn: how and when?
title_sort diagnosis of gluten-related enteropathy in a newborn: how and when?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820841/
https://www.ncbi.nlm.nih.gov/pubmed/31749915
work_keys_str_mv AT assandriroberto diagnosisofglutenrelatedenteropathyinanewbornhowandwhen
AT montanellialessandro diagnosisofglutenrelatedenteropathyinanewbornhowandwhen